Nura Bio raised $73.8M in a Series B funding round.
- Amount
- $73.8M
- Stage
- Series B
- Announced
- 22 June 2026
- Lead
- The Column Group
- Other investors
- Euclidean Capital, Samsara BioCapital, Sanofi Ventures
- Use of funds
- Fund clinical pipeline development, including the Phase 1b/2a study of NB-4746.
- Checked
- Amount and date checked against the press source